[Asia Economy Reporter Lee Seon-ae]



▲Bident=Decided not to dispose of investment securities in Bithumb Korea and Bithumb Holdings. The company explained, "This is the final response regarding the inquiry disclosure request about the rumor of disposal of investment securities in other corporations."


▲Zeus=Applied to transfer the listing of its subsidiary J.E.T from the Tokyo Pro Market to the Standard Market on the Tokyo Stock Exchange. Accordingly, plans to list a total of 1,945,000 issued shares. Among these, Zeus's shareholding ratio is 95.12% (1,850,000 shares). The company stated, "The number of shares to be listed and other details will be corrected after the demand forecast."


▲Audin Futures=Announced a shareholders' meeting to be convened on the 30th regarding amendments to the articles of incorporation including all convergence businesses related to the bio industry and all entertainment businesses, as well as director appointments.


▲Daeho Special Steel=Due to stock consolidation, trading of stock certificates will be suspended from the 18th until the day before the new stock certificate change listing date.


▲Sambo Industry=Recorded a derivative loss of 4.8 billion KRW due to exchange rate increase.


▲L&C Bio=Obtained product approval (NDA) for MegaCarti® for knee cartilage osteoarthritis treatment.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

▲Kangstem Biotech=Received approval for phase 1/2a clinical trial plan (IND) for Purestem-OA Kit.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing